The Philadelphia Phillies may be facing an uncomfortable pattern after new rumors surfaced involving outfielder Johan Rojas ahead of the 2026 World Baseball Classic.
Rojas was expected to represent the Dominican Republic in the upcoming tournament, but he was suddenly removed from the roster. Reports indicate the move may be connected to a failed test for a banned substance, though no official confirmation has yet been made regarding the details.
If the rumors prove accurate, it would mark the third Phillies player within the past year linked to a performance-enhancing drug suspension.
WBC Removal Raises Questions
The Dominican Republic team made the roster change earlier this week, with general manager Nelson Cruz announcing that Rojas would no longer participate in the tournament.
Rojas had been competing for playing time both with the national team and in Phillies spring training, where he was battling for an outfield role entering the 2026 season.
In his MLB action last year, the 23-year-old appeared in 71 games, posting:
- .224 batting average
- .569 OPS
While his offensive numbers were modest, Rojas’ defense and athleticism had kept him in the mix for a roster spot.
Now, his immediate future — both in the World Baseball Classic and with the Phillies — is uncertain.
A Concerning Pattern
If confirmed, Rojas’ case would follow two other recent Phillies PED suspensions.
The first involved reliever José Alvarado, who tested positive last May and received an 80-game suspension without pay. The punishment kept him out for the rest of the regular season and the entire postseason, a significant blow to Philadelphia’s bullpen.
Before the suspension, Alvarado had been one of the team’s most reliable relievers, finishing the year with:
- 4–2 record
- 3.81 ERA
- 32 strikeouts in 26 innings
The loss of his high-leverage innings was widely viewed as a major factor in the Phillies’ inability to make a deeper playoff run.
Another Case Earlier This Year
The second instance came with outfielder Max Kepler, who tested positive for a banned substance in January.
Kepler had signed a one-year deal with Philadelphia but struggled throughout the 2025 season. In 127 games, he produced:
- .216 batting average
- .300 OBP
- .391 slugging
- .691 OPS
Despite those modest numbers, his suspension stunned many around the league.
Kepler is currently a free agent and will begin serving his suspension immediately.
A Reputation at Risk
The Phillies have long been viewed as a disciplined and professional organization, making the recent string of PED-related cases particularly uncomfortable.
Even if Rojas’ situation remains only a rumor for now, the timing — following two other high-profile suspensions within a year — places the franchise under an unwanted spotlight.
Looking Ahead
Philadelphia will ultimately need to move forward regardless of how the situation develops.
With the 2026 season approaching, the club remains focused on returning to championship contention. But the lingering questions surrounding multiple drug test incidents may not disappear quickly.
For now, the Phillies and their fans are left waiting for clarity — and hoping this troubling trend doesn’t continue.
Leave a Reply